Jeffrey Dao
Amministratore Delegato presso Omnitura Therapeutics, Inc.
Profilo
Jeffrey Dao was the founder of Genyous Biomed International, Inc. (founded in 2005) where he held the title of President & Chief Operating Officer in 2007.
He is also the founder of Omnitura Therapeutics, Inc. (founded in 2001) where he currently holds the title of President & Co-Chief Executive Officer.
In his former positions, Mr. Dao worked as a Senior Director-Business Development at Oracle Corp.
and as a Vice President-Business Development at Nokia, Inc.
Posizioni attive di Jeffrey Dao
| Società | Posizione | Inizio |
|---|---|---|
Omnitura Therapeutics, Inc.
 Omnitura Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Omnitura Therapeutics, Inc. is a biopharmaceutical company engaged in the commercialization of Multifunctional Multitargeted pharmaceuticals for oncology, a new class of therapies that is design to address the fundamentally complex and heterogeneous nature of cancer. The firm's product Aneustat, is a non-toxic, orally delivered, multivalent I-O drug candidate design to intercept, treat, and prevent cancer. The company was founded by James Dao and Jeffrey Dao in 2001 and is headquartered in Burlingame, CA. | Amministratore Delegato | 01/01/2001 |
Precedenti posizioni note di Jeffrey Dao
| Società | Posizione | Fine |
|---|---|---|
Genyous Biomed International, Inc.
 Genyous Biomed International, Inc. Packaged SoftwareTechnology Services Genyous Biomed International, Inc. engages in the discovery, development, and manufacture of multifunctional multi targeted (MFMT) therapies to prevent, detect, and treat cancer and other chronic diseases. The firm offers MFMT therapies, which include anti-viral, anti-oxidative, anti-inflammatory, and immune modulating therapeutic effects for the treatment of solid tumors and related chronic diseases. The company was founded by Jeffrey Dao and James Dao in 2000 and is headquartered in and is headquartered in Henderson, NV. | Fondatore | 01/01/2007 |
Nokia, Inc.
 Nokia, Inc. Specialty TelecommunicationsCommunications Nokia, Inc. distributed and marketed mobile phones and telecommunication devices. It provided equipment, solutions, and services for network operators and corporations. The company was founded on March 19, 1999 and was headquartered in Irving, TX. | Corporate Officer/Principal | - |
| ORACLE CORPORATION | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ORACLE CORPORATION | Technology Services |
| Aziende private | 3 |
|---|---|
Nokia, Inc.
Nokia, Inc. Specialty TelecommunicationsCommunications Nokia, Inc. distributed and marketed mobile phones and telecommunication devices. It provided equipment, solutions, and services for network operators and corporations. The company was founded on March 19, 1999 and was headquartered in Irving, TX. | Communications |
Genyous Biomed International, Inc.
Genyous Biomed International, Inc. Packaged SoftwareTechnology Services Genyous Biomed International, Inc. engages in the discovery, development, and manufacture of multifunctional multi targeted (MFMT) therapies to prevent, detect, and treat cancer and other chronic diseases. The firm offers MFMT therapies, which include anti-viral, anti-oxidative, anti-inflammatory, and immune modulating therapeutic effects for the treatment of solid tumors and related chronic diseases. The company was founded by Jeffrey Dao and James Dao in 2000 and is headquartered in and is headquartered in Henderson, NV. | Technology Services |
Omnitura Therapeutics, Inc.
Omnitura Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Omnitura Therapeutics, Inc. is a biopharmaceutical company engaged in the commercialization of Multifunctional Multitargeted pharmaceuticals for oncology, a new class of therapies that is design to address the fundamentally complex and heterogeneous nature of cancer. The firm's product Aneustat, is a non-toxic, orally delivered, multivalent I-O drug candidate design to intercept, treat, and prevent cancer. The company was founded by James Dao and Jeffrey Dao in 2001 and is headquartered in Burlingame, CA. | Health Technology |
- Borsa valori
- Insiders
- Jeffrey Dao
